News on sequencing-based testing, NGS gene panels, & diagnostic exomes in genetics, genomics, and molecular diagnostics.
Investigators studied 442 patients with CUP and found mutations that could inform a specific treatment decision in more than half of them.
The SPRING trial is exploring a three-drug strategy, starting with Ibrance, Inlyta, and Bavencio, and will validate a biomarker algorithm for predicting responders.
The researchers plan to work with the NIH's Genome Research Alliance for Transplantation consortium to compare their method with others.
The company reported $35.0 million in revenues, driven by higher adoption of its molecular information solutions.
The company is collaborating with hospitals to implement sequencing and machine learning approaches to pinpoint the molecular etiology of autism earlier in age.
In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.
The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.
In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.
Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.
This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.
This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.